Literature DB >> 18922804

Estimates of HIV prevalence in a highly endemic area of China: Dehong Prefecture, Yunnan Province.

Yujiang Jia1, Jiangping Sun, Lu Fan, Duan Song, Shuming Tian, Yuecheng Yang, Manhong Jia, Lin Lu, Xinhua Sun, Sanguo Zhang, Andrzej Kulczycki, Sten H Vermund.   

Abstract

BACKGROUND: Dehong Prefecture in Yunnan Province, China, borders Myanmar. Its proximity to the 'Golden Triangle', one of the world's largest illicit drug production and distribution centre, contributes to drug trafficking and ready availability of heroin. Dehong's 1.1 million people confront a serious HIV problem fuelled by injection drug use. The aim of this study is to improve the 2005 estimates of the true status of the HIV/AIDS epidemic in Dehong Prefecture.
METHODS: We estimated the HIV prevalence by synthesizing the results from several data sources (HIV/AIDS case reports, surveys, surveillance activities and epidemiological studies). We applied three different statistical procedures for estimations: (i) The Workbook method, adapted to meet the estimation needs in Dehong Prefecture; (ii) An estimate based on antenatal clinical data; and (iii) a dynamic model based on the local epidemic pattern.
RESULTS: We estimated that the population prevalence for HIV infections in Dehong Prefecture is 1.3% (likely range from low/high of three estimates: 0.9-1.7%) such that 13 500 people were living with HIV/AIDS in Dehong Prefecture (likely range: 8,200-18,300) in 2005. Infections remain concentrated among injection drug users, female sex workers and their clients with an uneven geographical distribution of estimated cases.
CONCLUSION: More reliable estimates of HIV prevalence can be made by synthesizing multiple data sources using several procedures. Current HIV prevention, care and treatment challenges are judged substantial in Dehong Prefecture, regardless of what modelling strategy is used.

Entities:  

Mesh:

Year:  2008        PMID: 18922804      PMCID: PMC2638873          DOI: 10.1093/ije/dyn196

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  12 in total

1.  A qualitative study on HIV risk behaviors and medical needs of sex workers in a China/Myanmar border town.

Authors:  William C W Wong; Wang Yilin
Journal:  AIDS Patient Care STDS       Date:  2003-08       Impact factor: 5.078

2.  The workbook approach to making estimates and projecting future scenarios of HIV/AIDS in countries with low level and concentrated epidemics.

Authors:  N Walker; J Stover; K Stanecki; A E Zaniewski; N C Grassly; J M Garcia-Calleja; P D Ghys
Journal:  Sex Transm Infect       Date:  2004-08       Impact factor: 3.519

3.  Prevalence of HIV infection in the United States, 1984 to 1992.

Authors:  J M Karon; P S Rosenberg; G McQuillan; M Khare; M Gwinn; L R Petersen
Journal:  JAMA       Date:  1996-07-10       Impact factor: 56.272

4.  Estimating population prevalence of human immunodeficiency virus infection in urban areas with high rates of intravenous drug use: a model of the Bronx in 1988.

Authors:  E Drucker; S H Vermund
Journal:  Am J Epidemiol       Date:  1989-07       Impact factor: 4.897

Review 5.  The current status of methods for estimating the prevalence of human immunodeficiency virus in the United States of America.

Authors:  J M Karon; M Khare; P S Rosenberg
Journal:  Stat Med       Date:  1998-01-30       Impact factor: 2.373

6.  How well do antenatal clinic (ANC) attendees represent the general population? A comparison of HIV prevalence from ANC sentinel surveillance sites with a population-based survey of women aged 15-49 in Cambodia.

Authors:  Vonthanak Saphonn; Leng Bun Hor; Sun Penh Ly; Samrith Chhuon; Tobi Saidel; Roger Detels
Journal:  Int J Epidemiol       Date:  2002-04       Impact factor: 7.196

7.  Community-based trial to prevent drug use among youths in Yunnan, China.

Authors:  Zunyou Wu; Roger Detels; Jiapeng Zhang; Virginia Li; Jianhua Li
Journal:  Am J Public Health       Date:  2002-12       Impact factor: 9.308

8.  [The natural history of HIV infection among IDUs in Ruili, Yunnan province, China].

Authors:  X Zheng; J Zhang; X Wang; S Duan; S Qu; Y Duan; G Zhang
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2000-02

9.  Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

Authors:  E M Connor; R S Sperling; R Gelber; P Kiselev; G Scott; M J O'Sullivan; R VanDyke; M Bey; W Shearer; R L Jacobson
Journal:  N Engl J Med       Date:  1994-11-03       Impact factor: 91.245

10.  Acceptability study of sex workers attending the HIV/ AIDS clinic in Ruili, China.

Authors:  William-C W Wong
Journal:  Asia Pac J Public Health       Date:  2003       Impact factor: 1.399

View more
  29 in total

1.  Dynamic mathematical models of HIV/AIDS transmission in China.

Authors:  Jun-jie Wang; Kathleen Heather Reilly; Jing Luo; Chun-peng Zang; Ning Wang
Journal:  Chin Med J (Engl)       Date:  2010-08-05       Impact factor: 2.628

2.  Bisexual behavior and infection with HIV and syphilis among men who have sex with men along the east coast of China.

Authors:  Meizhen Liao; Dianming Kang; Baofa Jiang; Xiaorun Tao; Yueshen Qian; Tongzhan Wang; Zhenqiang Bi; Yan Xiao; Chunmei Li; Pingsheng Wu; Sten H Vermund; Yujiang Jia
Journal:  AIDS Patient Care STDS       Date:  2011-09-16       Impact factor: 5.078

3.  HPV prevalence and cervical intraepithelial neoplasia among HIV-infected women in Yunnan Province, China: a pilot study.

Authors:  Hong-Yun Zhang; Sarah M Tiggelaar; Vikrant V Sahasrabuddhe; Jennifer S Smith; Cheng-Qin Jiang; Run-Bo Mei; Xian-Guo Wang; Zu-An Li; You-Lin Qiao
Journal:  Asian Pac J Cancer Prev       Date:  2012

4.  Prevalence of the VNIc genotype of Cryptococcus neoformans in non-HIV-associated cryptococcosis in the Republic of Korea.

Authors:  Young Hwa Choi; Popchai Ngamskulrungroj; Ashok Varma; Edward Sionov; Soo Myung Hwang; Fabian Carriconde; Wieland Meyer; Anastasia P Litvintseva; Wee Gyo Lee; Jong Hee Shin; Eui-Chong Kim; Kyung Won Lee; Tae Yeal Choi; Yeong Seon Lee; Kyung J Kwon-Chung
Journal:  FEMS Yeast Res       Date:  2010-05-19       Impact factor: 2.796

5.  Projecting dynamic trends for HIV/AIDS in a highly endemic area of China: estimation models for Liangshan Prefecture, Sichuan Province.

Authors:  Li Liu; Rongsheng Luan; Wen Yang; Linglin Zhang; Jianhua Zhang; Lei Nan; Jun Huang; Ying Hu; Guangyu Mao; Liao Feng; Yuhan Gong; Sten H Vermund; Yujiang Jia
Journal:  Curr HIV Res       Date:  2009-07       Impact factor: 1.581

6.  Estimation of HIV-1 incidence among five focal populations in Dehong, Yunnan: a hard hit area along a major drug trafficking route.

Authors:  Song Duan; Sheng Shen; Marc Bulterys; Yujiang Jia; Yuecheng Yang; Lifeng Xiang; Fei Tian; Lin Lu; Yao Xiao; Minjie Wang; Manhong Jia; Huazhou Jiang; Sten H Vermund; Yan Jiang
Journal:  BMC Public Health       Date:  2010-04-07       Impact factor: 3.295

Review 7.  HIV among injecting drug users: current epidemiology, biologic markers, respondent-driven sampling, and supervised-injection facilities.

Authors:  Don C Des Jarlais; Kamyar Arasteh; Salaam Semaan; Evan Wood
Journal:  Curr Opin HIV AIDS       Date:  2009-07       Impact factor: 4.283

8.  Sources of data for improved surveillance of HIV/AIDS in China.

Authors:  Yujiang Jia; Fan Lu; Xinhua Sun; Sten H Vermund
Journal:  Southeast Asian J Trop Med Public Health       Date:  2007-11       Impact factor: 0.267

9.  Retention and HIV seroconversion among drug users on methadone maintenance treatment in Yunnan, China.

Authors:  Y-P Chang; L Duo; A M V Kumar; S Achanta; H-M Xue; S Satyanarayana; R Ananthakrishnan; S Srivastava; W Qi; S-Y Hu
Journal:  Public Health Action       Date:  2014-03-21

10.  High prevalence of HIV, HCV, HBV and co-infection and associated risk factors among injecting drug users in Yunnan province, China.

Authors:  Yan-Heng Zhou; Zhi-Hong Yao; Feng-Liang Liu; Hong Li; Li Jiang; Jia-Wu Zhu; Yong-Tang Zheng
Journal:  PLoS One       Date:  2012-08-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.